Tactile Systems Technology Inc
NASDAQ:TCMD

Watchlist Manager
Tactile Systems Technology Inc Logo
Tactile Systems Technology Inc
NASDAQ:TCMD
Watchlist
Price: 13.86 USD 1.91%
Market Cap: 327m USD

Tactile Systems Technology Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tactile Systems Technology Inc
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Tactile Systems Technology Inc
NASDAQ:TCMD
Other Liabilities
$17.4m
CAGR 3-Years
-16%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Other Liabilities
$937m
CAGR 3-Years
-5%
CAGR 5-Years
-10%
CAGR 10-Years
0%
Boston Scientific Corp
NYSE:BSX
Other Liabilities
$1.8B
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
Stryker Corp
NYSE:SYK
Other Liabilities
$2.5B
CAGR 3-Years
-3%
CAGR 5-Years
-1%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Other Liabilities
$6.7B
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
3%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Tactile Systems Technology Inc
Glance View

Market Cap
331m USD
Industry
Health Care

Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

TCMD Intrinsic Value
16.49 USD
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Tactile Systems Technology Inc's Other Liabilities?
Other Liabilities
17.4m USD

Based on the financial report for Dec 31, 2024, Tactile Systems Technology Inc's Other Liabilities amounts to 17.4m USD.

What is Tactile Systems Technology Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
0%

Over the last year, the Other Liabilities growth was -15%. The average annual Other Liabilities growth rates for Tactile Systems Technology Inc have been -16% over the past three years .

Back to Top